These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17035932)

  • 21. Blockade of mineralocorticoid receptors enhances naïve T-helper cell counts during early sleep in humans.
    Besedovsky L; Born J; Lange T
    Brain Behav Immun; 2012 Oct; 26(7):1116-21. PubMed ID: 22884414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals.
    Otte C; Wingenfeld K; Kuehl LK; Kaczmarczyk M; Richter S; Quante A; Regen F; Bajbouj M; Zimmermann-Viehoff F; Wiedemann K; Hinkelmann K
    Neuropsychopharmacology; 2015 Jan; 40(2):386-93. PubMed ID: 25035081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans.
    Rimmele U; Besedovsky L; Lange T; Born J
    Neuropsychopharmacology; 2013 Apr; 38(5):884-94. PubMed ID: 23303058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors.
    Kuningas M; de Rijk RH; Westendorp RG; Jolles J; Slagboom PE; van Heemst D
    Neuropsychopharmacology; 2007 Jun; 32(6):1295-301. PubMed ID: 17133261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
    Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D; Leicht G; Baghai T; Pogarell O; Schüle C; Karch S; Nothdurfter C; Rupprecht R; Mulert C
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid receptor function in major depression.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    Arch Gen Psychiatry; 2003 Jan; 60(1):24-8. PubMed ID: 12511169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J
    CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum.
    Vogel S; Klumpers F; Krugers HJ; Fang Z; Oplaat KT; Oitzl MS; Joëls M; Fernández G
    Neuropsychopharmacology; 2015 Mar; 40(4):947-56. PubMed ID: 25355243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation.
    Otte C; Wingenfeld K; Kuehl LK; Richter S; Regen F; Piber D; Hinkelmann K
    J Psychiatr Res; 2015 Oct; 69():120-5. PubMed ID: 26343603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.
    Heuser I; Deuschle M; Weber B; Stalla GK; Holsboer F
    Psychoneuroendocrinology; 2000 Jul; 25(5):513-8. PubMed ID: 10818284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age.
    Heuser I; Deuschle M; Weber A; Kniest A; Ziegler C; Weber B; Colla M
    Neurobiol Aging; 2000; 21(4):585-9. PubMed ID: 10924776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A
    Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K; Jahn H; Yassouridis A; Kellner M
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J
    Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.
    Eser D; Schüle C; Baghai T; Floesser A; Krebs-Brown A; Enunwa M; de la Motte S; Engel R; Kucher K; Rupprecht R
    Psychopharmacology (Berl); 2007 Jul; 192(4):479-87. PubMed ID: 17318504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The modulatory effects of corticosteroids on cognition: studies in young human populations.
    Lupien SJ; Wilkinson CW; Brière S; Ménard C; Ng Ying Kin NM; Nair NP
    Psychoneuroendocrinology; 2002 Apr; 27(3):401-16. PubMed ID: 11818174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.